Log in

CMA welcomes new approval pathway as part of a world class regulatory regime

16 Feb 2018 1:27 PM | Anonymous

Mr Carl Gibson, ceo of Complementary Medicines Australia (CMA) said: “We applaud the continued implementation of the government agreed recommendations from the Medicines and Medical Devices Review (MMDR), including amendments to provide a new approval pathway for listing complementary medicines with higher therapeutic indications and health claims.”

To read more click here

Call us on 02 6260 4022 or fax 02 6260 4122
Follow us online

Address: PO Box 450 Mawson, ACT 2607 Australia

Powered by Wild Apricot Membership Software